Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

ADALIMUMAB-RYVK

FDA · BLA · 2025-11-06

AgencyFDA
Submission typeBLA
Action date2025-11-06
BrandSIMLANDI
SponsorALVOTECH USA INC
RouteINJECTION

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:35:06.972Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:ADALIMUMAB-RYVK:2025-11-06

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

ADALIMUMAB-RYVK — approval | AEaH